| 标题 |
 32O 5-year (y) overall survival (OS) with maintenance olaparib (ola) plus bevacizumab (bev) by clinical risk in patients (pts) with newly diagnosed advanced ovarian cancer (AOC) in the phase III PAOLA-1/ENGOT-ov25 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊：ESMO Open 作者：D. Lorusso; M. Mouret-Reynier; P. Harter; C. Cropet; C. Caballero Díaz; et al 出版日期：2023-02-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
秋风
Nole
cdercder
Enigma_GEB
DW
无极微光
Kao
拆迁办禁言
谢雷XIELei
coolru
老的火龙果
热切菩萨
xing_xing
贪玩的秋柔
嘻嘻哈哈
aajhajkahna
渡人舟
OK
苹果老太
极限001
皖公网安备34019202002308
